Sanofi and Canadian Alliance Sign Sarclisa Letter of Intent
The agreement is a step toward public access to Sarclisa for newly diagnosed, transplant-ineligible multiple myeloma patients.
The agreement is a step toward public access to Sarclisa for newly diagnosed, transplant-ineligible multiple myeloma patients.